The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Kindler, Hedy
One or more keywords matched the following items that are connected to Kindler, Hedy
Item TypeName
Concept Survival Analysis
Academic Article Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer.
Academic Article Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
Academic Article The pemetrexed/gemcitabine combination in pancreatic cancer.
Academic Article Phase II study of flavopiridol in patients with advanced colorectal cancer.
Academic Article Weekly, high-dose paclitaxel in advanced lung carcinoma: a phase II study with pharmacokinetics by the Cancer and Leukemia Group B.
Academic Article A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.
Academic Article A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Academic Article Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Academic Article Antiangiogenic therapies for mesothelioma.
Academic Article Randomized phase II study of gemcitabine administered at a fixed dose rate or in combination with cisplatin, docetaxel, or irinotecan in patients with metastatic pancreatic cancer: CALGB 89904.
Academic Article Phase I and pharmacokinetic study of erlotinib for solid tumors in patients with hepatic or renal dysfunction: CALGB 60101.
Academic Article Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Academic Article Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
Academic Article Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Academic Article Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303).
Academic Article A Phase II trial of fixed dose rate gemcitabine in patients with advanced biliary tree carcinoma.
Academic Article Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study.
Academic Article Putative predictive biomarkers of survival in patients with metastatic pancreatic adenocarcinoma treated with gemcitabine and ganitumab, an IGF1R inhibitor.
Academic Article A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Academic Article Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
Academic Article A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Academic Article Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
Academic Article The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance).
Academic Article Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study.
Search Criteria
  • Survival Analysis